Huiying Gu
No. 183 Xinqiao High Street
Tanjiagang, 400037, China
Tanjiagang, 400037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Journal: Cancer research
Published: October 09, 2025
Lipid droplet-associated gene signatures classify metabolic subtypes and identify PLIN3 as a key driver in hepatocellular carcinoma.
Journal: Genes & diseases
Published: May 22, 2025
RPL6 Interacts with HMGCS1 to Stabilize HIF-1α by Promoting Cholesterol Production in Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 21, 2025
Statin is associated with higher cortical thickness in early Alzheimer's disease.
Journal: Experimental gerontology
Published: August 16, 2024
Targeting PTEN in ischemic stroke: From molecular mechanisms to therapeutic potentials.
Journal: Experimental neurology
Published: July 09, 2024
Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: December 09, 2023
A Nomogram Model for Predicting the Response to Transcatheter Arterial Embolization in Patients With Symptomatic Hepatic Hemangioma.
Journal: Frontiers in molecular biosciences
Published: June 10, 2021
Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: January 25, 2021
Liver Parenchyma Transection-First Approach for Laparoscopic Left Hemihepatectomy: A Propensity Score Matching Analysis.
Journal: World journal of surgery
Published: October 11, 2020
Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes.
Journal: Molecular therapy. Methods & clinical development
Published: April 22, 2020
Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Journal: Cancer biomarkers : section A of Disease markers
Published: July 20, 2019
Last Updated: 09/26/2026